- Home
- OSW vs APLS Comparison
OSW vs APLS Comparison
Compare OSW & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSW | APLS |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | Bahamas | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.7B |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | OSW | APLS |
|---|---|---|
| Price | $20.40 | $20.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 20 |
| Target Price | $25.00 | ★ $31.89 |
| AVG Volume (30 Days) | ★ 2.0M | 1.8M |
| Earning Date | 05-21-2026 | 04-02-2026 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | N/A | ★ 112.50 |
| EPS | ★ 0.69 | 0.20 |
| Revenue | $961,001,000.00 | ★ $1,003,782,000.00 |
| Revenue This Year | $7.49 | N/A |
| Revenue Next Year | $7.65 | $17.97 |
| P/E Ratio | ★ $30.29 | $100.68 |
| Revenue Growth | 7.37 | ★ 28.46 |
| 52 Week Low | $14.21 | $16.10 |
| 52 Week High | $23.54 | $30.48 |
Technical Indicators
Market Signals| Indicator | OSW | APLS |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 36.54 |
| Support Level | $19.05 | $18.95 |
| Resistance Level | $22.93 | $20.42 |
| Average True Range (ATR) | 0.89 | 0.96 |
| MACD | -0.23 | -0.19 |
| Stochastic Oscillator | 9.63 | 18.84 |
Price Performance
Historical ComparisonAbout OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.